Online Resource 2- Excluded documents
Document / Reason for DecisionA practical critique of antifungal treatment guidelines for haemato-oncologists (Agrawal et al) [1] / Review of guidelines
Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients (Centres for Disease Control et al) [2] / Duplicate publication of included guideline
Guidelines for the management of bacterial and fungal infections during chemotherapy for pediatric acute leukemia or solid tumors: what is available in 2010? (Castagnola et al) [3] / Not a Clinical Practice Guideline
Guidelines for the management of intravascular catheter- related infections (Mermel et al) [4] / Earlier version of an included guideline
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections (Edwards et al) [5] / Consensus statement only
NCCN: Fever and neutropenia (Wade et al) [6] / Editorial
NCCN: Prevention and treatment of cancer-related infections (Baden et al) [7] / Adult only guideline
New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients. (Mendes et al) [8] / Review of guidelines
Supportive treatment for cancer - Part 2: Prevention and treatment of adverse events related to chemotherapy and radiotherapy (Verleye et al) [9] / Adult only guideline
Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators (Buchner et al) [10] / Consensus statement only
Diagnosis of invasive fungal infections in hematology and oncology - guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO) (Ruhnke et al) [11] / Adult only guideline
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. (Cornely et al) [12] / Adult only guideline
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)(Mousset et al) [13] / Adult only guideline
[Consensus on management of children with cancer, neutropenia and fever: Update 2008-2009] (Comité Nacional de Infectología Pediátrica) [14] / Paper in Spanish
[Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update] (Fortún et al) [15] / Paper in Spanish
[Spanish Paediatric Infectious Diseases Society consensus document on the treatment of fungal infections based on the immune response] (Martín et al) [16] / Paper in Spanish
[The Spanish Society of Paediatric Infectious Diseases (SEIP) recommendations on the diagnosis and management of invasive candidiasis] (Figueras et al) [17] / Paper in Spanish
[Treatment of invasive fungal infections. 2005. Andalusian Infectious Disease Society] (Pachón et al) [18] / Paper in Spanish
ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures (Cuenca-Estrella et al) [19] / Diagnostic guideline only
References
1. Agrawal S, Jones B, Barnes R, et al. (2012) A practical critique of antifungal treatment guidelines for haemato-oncologists. Crit Rev Microbiol 38:203–216. doi: 10.3109/1040841X.2011.645521
2. Centers for Disease Control and Prevention, Infectious Disease Society of America, American Society of Blood and Marrow Transplantation (2000) Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control 49:1–125, CE1–7.
3. Castagnola E, Caviglia I, Haupt R (2011) Guidelines for the management of bacterial and fungal infections during chemotherapy for pediatric acute leukemia or solid tumors: what is available in 2010? Pediatr Rep 3:e7. doi: 10.4081/pr.2011.e7
4. Mermel LA, Farr BM, Sherertz RJ, et al. (2001) Guidelines for the management of intravascular catheter-related infections. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am 22:222–242. doi: 10.1086/501893
5. Edwards JE Jr, Bodey GP, Bowden RA, et al. (1997) International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis Off Publ Infect Dis Soc Am 25:43–59.
6. Wade JC, Rubenstein EB, NCCN Fever and Neutropenia Practice Guidelines Panel (2001) NCCN: Fever and neutropenia. Cancer Control J Moffitt Cancer Cent 8:16–21.
7. Baden LR, Bensinger W, Angarone M, et al. (2012) Prevention and treatment of cancer-related infections. J Natl Compr Cancer Netw JNCCN 10:1412–1445.
8. Mendes AVA, Sapolnik R, Mendonça N (2007) New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients. J Pediatr (Rio J) 83:S54–63. doi: 10.2223/JPED.1624
9. Verleye L, van de Wetering F, Heus P, et al. (2012) Supportive treatment for cancer - Part 2: Prevention and treatment of adverse events related to chemotherapy and radiotherapy. Belgian Health Care Knowledge Centre (KCE), Brussels
10. Büchner T, Fegeler W, Bernhardt H, et al. (2002) Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 21:337–352. doi: 10.1007/s10096-002-0730-4
11. Ruhnke M, Böhme A, Buchheidt D, et al. (2012) Diagnosis of invasive fungal infections in hematology and oncology - guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO). Ann Oncol 23:823–833. doi: 10.1093/annonc/mdr407
12. Cornely OA, Böhme A, Buchheidt D, et al. (2009) Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica 94:113–122. doi: 10.3324/haematol.11665
13. Mousset S, Buchheidt D, Heinz W, et al. (2014) Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 93:13–32.
14. Comité Nacional de Infectología Pediátrica (2010) [Consensus on management of children with cancer, neutropenia and fever: Update 2008-2009]. Arch Argent Pediatría 108:e47–70. doi: 10.1590/S0325-00752010000200022
15. Fortún J, Carratalá J, Gavaldá J, et al. (2011) [Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update]. Enfermedades Infecc Microbiol Clínica 29:435–454. doi: 10.1016/j.eimc.2011.01.010
16. Martín A, Soler-Palacín P, Español T, et al. (2010) [Spanish Paediatric Infectious Diseases Society consensus document on the treatment of fungal infections based on the immune response]. An Pediatría Barc Spain 2003 73:362.e1–8. doi: 10.1016/j.anpedi.2010.04.016
17. Figueras C, Díaz de Heredia C, García JJ, et al. (2011) [The Spanish Society of Paediatric Infectious Diseases (SEIP) recommendations on the diagnosis and management of invasive candidiasis]. An Pediatría Barc Spain 2003 74:337.e1–337.e17. doi: 10.1016/j.anpedi.2010.12.012
18. Pachón J, Cisneros JM, Collado-Romacho AR, et al. (2006) [Treatment of invasive fungal infections. 2005. Andalusian Infectious Disease Society]. Enfermedades Infecc Microbiol Clínica 24:254–263.
19. Cuenca-Estrella M, Verweij PE, Arendrup MC, et al. (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 18:9–18. doi: 10.1111/1469-0691.12038